Interleukin-1β upregulates tissue-type plasminogen activator in a keratinocyte cell line (HaCaT)

Archives of Dermatological Research

Volumn 288, Issue 9, 1996, Pages 554-558

  Rox, Jutta M ^a   Reinartz, Jeannette ^a   Kramer, Michael D ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Inflammation; Interleukin 1 beta; Tissue type plasminogen activator

Indexed keywords

INTERLEUKIN 1BETA; PLASMIN; PLASMINOGEN; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; CELL LINE; CONTROLLED STUDY; EPIDERMIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; KERATINOCYTE; PEMPHIGOID; PEMPHIGUS; PRIORITY JOURNAL; PSORIASIS;

EID: 0029771622     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02505254     Document Type: Article

References (36)

1. Baird J, Lazarus GS, Belin D, Vassalli J-D, Busso N, Gubler P, Jensen PJ (1990) mRNA for tissue-type plasminogen activator is present in lesional epidermis from patients with psoriasis, pemphigus, or bullous pemphigoid, but is not detected in normal epidermis. J Invest Dermatol 95 : 548-552
2. Barker JNWN, Mitra RS, Griffiths CEM, Dixit VM, Nickoloff BJ (1991) Keratinocytes as initiators of inflammation. Lancet 337 : 211-214
3. Black RA, Kronheim SR, Cantrell M, Deeley MC, March CJ, Prickett KS, Wignall J, Conlon PJ, Cosman D, Hopp TP, Mochizuki DY (1988) Generation of biologically active interleukin-1 beta by proteolytic cleavage of the inactive precursor. J Biol Chem 263 : 9437-9442
4. Borenfreund E, Puerner JA (1985) Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicol Lett 24 : 119-124
5. Boukamp P, Petrusevska RT, Breitkreuz D, Hornung J, Markhum A, Fusenig NE (1988) Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106 : 761-771
6. Buessecker F, Reinartz J, Schirmer U, Kramer MD (1993) Enzyme-linked immunosorbent assays for plasminogen activators. J Immunol Methods 162 : 193-200
7. Buessecker F, Reinartz J, Kramer MD (1995) tPA of human keratinocytes: contribution to cell-surface-associated plasminogen activation and upregulation by retinoic acid. Exp Dermatol 4 : 357-364
8. Burge SM, Marshall JM, Cederholm-Williams SA (1992) Plasminogen binding sites in normal human skin. Br J Dermatol 126 : 35-41
9. Chomczynski P, Sacchi N (1986) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biocehm 162 : 156-159
10. Danö K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nielsen LS, Skriver L (1989) Plasminogen activators and cancer. Adv Cancer Res 1-225
11. Dinarello CA (1991) Interleukin-1 and interleukin-1 antagonism. Blood 77 : 1627-1652
12. Dower SK, Qwarnstrom EE, Page RC, Blanton RA, Kupper TS, Raines E, Ross R, Sims JE (1990) Biology of the interleukin-1 receptor. J Invest Dermatol 94 : 68S-73S
13. Finlay GJ, Baguley BC, Wilson WR (1984) A semiautomated microculture method tor investigating growth inhibitory effects of cytotoxic compounds on exponentially growing carcinoma cells. Anal Biochem 139 : 272-277
14. Friberger P (1982) Chromogenic peptide substrates. Their use for the assay of factors in the fibrinolytic and the plasma kallikreinkinin systems. Scand J Clin Lab Invest 42 [Suppl 162] : 1-98
15. Gabring LC, Buckley A, Daynes RA (1985) Presence of epidermal-derived thymocyte activating factor/interleukin 1 in normal human stratum corneum. J Clin Invest 76 : 1585-1591
16. Gissler HM, Frank R, Kramer MD (1993) Immunohistochemical characterization of the plasminogen activator system in psoriatic epidermis. Br J Dermatol 128 : 612-618
17. Grando SA, Glukhenky BT, Drannik GN, Epshtein EV, Kostromin AP, Korostash TA (1989) Mediators of inflammation in blister fluids from patients with pemphigus vulgaris and bullous pemphigoid. Arch Dermatol 125 : 925-930
18. Grondahl-Hansen J, Ralfkiaer E, Nielsen LS, Kristensen P, Freutz G, Danö K (1987) Immunohistochemical localization of urokinase- and tissue-type plasminogen activators in psoriatic skin. J Invest Dermatol 88 : 28-32
19. Harris TJR, Patel T, Marston FAP, Little S, Emtage JS, Opdenakker G, Volckaert G, Rombauts W, Billiau A, De Somer P (1986) Cloning of cDNA coding for human tissue-type plasminogen activator and its expression in Escherichia coli. Mol Biol Med 3 : 279-292
20. Hashimoto K, Singer KH, Lide WB, Shafran K, Webber P, Morioka S, Lazarus GS (1983) Plasminogen activator in cultured human epidermal cells. J Invest Dermatol 81 : 424-429
21. Jensen P, John M, Baird J (1990) Urokinase and tissue type plasminogen activators in human keratinocyte culture. Exp Cell Res 187 : 162-169
22. Jensen PJ, Baird J, Morioka S, Lessin S, Lazarus GS (1988) Epidermal plasminogen activator is abnormal in cutaneous lesions. J Invest Dermatol 90 : 777-782
23. Jobling SA, Auron PE, Gurka G, Webb AC, McDonald B, Rosenwasser LJ, Gehrke L (1988) Biological activity and receptor binding of human prointerleukin-1 beta and subpeptides. J Biol Chem 263 : 16372-16378
24. Kapp A (1993) Die Rolle von Zytokinen für die Pathogenese der Psoriasis. Hautarzt 44 : 201-207
25. Kramer MD, Reinartz J, Schaefer B (1995) Plasminogen activation by human keratinocytes: molecular pathways and cell-biological consequences. Biol Chem Hoppe Seyler 376 : 131-141
26. Kupper TS (1990) Immune and inflammatory processes in cutaneous tissues. Mechanisms and speculations. J Clin Invest 86 : 1783-1789
27. Kupper TS, Chua AO, Flood P, McGuire J, Gubler U (1987) Interleukin 1 gene expression in cultured human keratinocytes is augmented by ultraviolet irradiation. J Clin Invest 80 : 430-436
28. Mizutani H, Black R, Kupper TS (1991) Human keratinocytes produce but do not process pro-interleukin-1 (IL-1) beta. J Clin Invest 87 : 1066-1071
29. Mizutani H, Schechter N, Lazarus G, Black RA, Kupper TS (1991) Rapid and specific conversion of precursor interleukin 1 beta (IL-1 beta) to an active IL-1 species by human mast cell chymase. J Exp Med 174 : 821-825
30. Morioka S, Jensen PJ, Lazarus GS (1985) Human epiderma plasminogen activator. Characterization, localisation, ant modulation. Exp Cell Res 161 : 364-372
31. Prens EP, Benne K, Van Damme J Bakkus M, Brakel K, Ben ner R, van Joost Th (1990) Interleukin-1 and Interleukin-6 in psoriasis. J Invest Dermatol 95 : 121S-124S
32. Reinartz J, Batrla R, Boukamp P, Fusenig N, Kramer MD (1993) Binding and activation of plasminogen at the surface o human keratinocytes. Exp Cell Res 208 : 197-208
33. Reinartz J, Näher H, May H, Kramer MD (1993) Plasminoge activation in lesional skin of pemphigus vulgaris typ Neumanr Arch Dermatol Res 284 : 432-439
34. Spiers EM, Lazarus GS, Lyons Giordano B (1994) Expressio of plasminogen activator enzymes in psoriatic epidermis. J Invest Dermatol 102 : 333-338
35. Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howar AD, Kostura MJ, Miller DK, Molineaux SM, Weidner JP Aunins J, et al (1992) A novel helerodimeric cysteine proteas is required for interleukin-1 beta processing in monocytes. Nature 356 : 768-774
36. Vassalli J-D, Sappino A-P, Belin D (1991) The plasminoge activator/plasmin system. J Clin Invest 88 : 1067-1072